Loading
If this is the first time anyone has visited this substance, we may be fetching live data from TGA Product Information, PBS, and state framework sources — that can take up to a minute. Cached substances load in a second or two.
Anaemia associated with intrinsic renal disease Clinical criteria: Patient must require transfusion, AND Patient must have a haemoglobin level of less than 100 g per L, AND Patient must have intrinsic renal disease, as assessed by a nephrologist.
“Erythropoietin is a growth factor for erythroid development.”
“Following IV administration in CKD patients, the observed terminal elimination half-life (t 1/2 ) for Mircera was 134 hours, and the total systemic clearance was 0.494 mL/hr/kg. Following SC administration the t 1/2 was 139 hours in dialysis patients and 142 hours in patients not on dialysis.”
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.